USE OF AN OLIGOSACARID INHIBITOR OF FACTOR XA IN COMBINATION WITH AN ANTIAGREGANTE PLAQUETARIO FOR THE TREATMENT OF ARTERIAL THROMBOSIS.

摘要

Use of an indirect factor Xa inhibitor oligosaccharide that acts through antithrombin III, in combination with one or more compounds with platelet antiaggregant activity antagonists of glycoprotein IIb / IIIa chosen from - N- (1-ethoxycarbonylmethyl-piperidin-4 -yl) -N- {4- [4 - {(N-ethoxycarbonylimino) (amino) methyl} -phenyl] -thiazol-2-yl} -3-aminopropionate ethyl, - N- (1-carboxymethyl-piperidine- 4-yl) -N- {4- [4 - {(amino) (imino) methyl} phenyl] -thiazol-2-yl} -3-aminopropionic, and pharmaceutically acceptable salts thereof, for the preparation of medicaments intended to prevent and treat arterial thromboembolic diseases.